TREM2 is down-regulated by HSV1 in microglia and involved in antiviral defense in the brain
暂无分享,去创建一个
H. Zetterberg | S. Paludan | L. Reinert | Marcus Henricsson | Henrik Zetterberg | Stefanie Fruhwürth | Carl Öberg | Marcelina Sakr | Marcelina Sakr
[1] S. Paludan,et al. Microglia Activate Early Antiviral Responses upon Herpes Simplex Virus 1 Entry into the Brain to Counteract Development of Encephalitis-Like Disease in Mice , 2022, Journal of virology.
[2] L. Piccio,et al. Soluble TREM2: Innocent bystander or active player in neurological diseases? , 2022, Neurobiology of Disease.
[3] P. S. St George-Hyslop,et al. Does Soluble TREM2 Protect Against Alzheimer's Disease? , 2022, Frontiers in Aging Neuroscience.
[4] P. Kessler,et al. STING-Mediated Interferon Induction by Herpes Simplex Virus 1 Requires the Protein Tyrosine Kinase Syk , 2021, mBio.
[5] Xiaochen Bo,et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.
[6] G. Gao,et al. Critical role of Syk-dependent STAT1 activation in innate antiviral immunity. , 2021, Cell reports.
[7] C. Cotman,et al. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer’s disease , 2020, Nature Communications.
[8] J. Nyengaard,et al. Brain immune cells undergo cGAS-STING-dependent apoptosis during herpes simplex virus type 1 infection. , 2020, The Journal of clinical investigation.
[9] S. Rivest,et al. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis , 2020, Journal of Virology.
[10] Li-Na Zhang,et al. Independent and Correlated Role of Apolipoprotein E ɛ4 Genotype and Herpes Simplex Virus Type 1 in Alzheimer's Disease. , 2020, Journal of Alzheimer's disease : JAD.
[11] H. Rhinn,et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model , 2020, The Journal of experimental medicine.
[12] H. Zetterberg,et al. HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection , 2020, The Journal of experimental medicine.
[13] M. Simons,et al. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region , 2020, EMBO molecular medicine.
[14] G. Boivin,et al. Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis , 2020, Clinical Microbiology Reviews.
[15] R. Rizzo,et al. HHV-6A infection induces amyloid-beta expression and activation of microglial cells , 2019, Alzheimer's Research & Therapy.
[16] A. Mailles,et al. Herpes simplex virus encephalitis update , 2019, Current opinion in infectious diseases.
[17] Huaxi Xu,et al. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model , 2019, Nature Communications.
[18] D. Holtzman,et al. Loss of TREM2 function increases amyloid seeding but reduces plaque associated ApoE , 2018, Nature Neuroscience.
[19] E. Masliah,et al. Alterations in brain TREM2 and Amyloid‐β levels are associated with neurocognitive impairment in HIV‐infected persons on antiretroviral therapy , 2018, Journal of neurochemistry.
[20] H. Neumann,et al. Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis , 2018, Cell reports.
[21] D. Holtzman,et al. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight , 2018, Nature Reviews Immunology.
[22] Shuang Pan,et al. Herpes Simplex Virus 1 γ134.5 Protein Inhibits STING Activation That Restricts Viral Replication , 2018, Journal of Virology.
[23] J. Trojanowski,et al. Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration , 2018, Alzheimer's & Dementia.
[24] T. Hortobágyi,et al. Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms , 2018, Acta Neuropathologica.
[25] C. Zheng,et al. Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates cGAS/STING-Mediated Antiviral Innate Immunity , 2018, Journal of Virology.
[26] L. Piccio,et al. The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity , 2018, Immunity.
[27] I. Amit,et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.
[28] D. Kober,et al. TREM2-Ligand Interactions in Health and Disease. , 2017, Journal of molecular biology.
[29] J. Nyengaard,et al. Sensing of HSV-1 by the cGAS–STING pathway in microglia orchestrates antiviral defence in the CNS , 2016, Nature Communications.
[30] L. Enquist,et al. HSV‐1 ICP27 targets the TBK1‐activated STING signalsome to inhibit virus‐induced type I IFN expression , 2016, The EMBO journal.
[31] D. Holtzman,et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques , 2016, The Journal of experimental medicine.
[32] D. Leib,et al. Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1 , 2015, Journal of Virology.
[33] T. Ørntoft,et al. Functional IRF3 deficiency in a patient with herpes simplex encephalitis , 2015, The Journal of experimental medicine.
[34] G. Eslick,et al. Herpes Viruses Increase the Risk of Alzheimer's Disease: A Meta-Analysis. , 2015, Journal of Alzheimer's disease : JAD.
[35] J. Molinuevo,et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.
[36] Zhijian J. Chen,et al. Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.
[37] A. Hofman,et al. Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.
[38] D. Chaussabel,et al. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood , 2012, The Journal of experimental medicine.
[39] W. Seaman,et al. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia , 2009, Journal of neurochemistry.
[40] G. Barber,et al. STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling , 2008, Nature.
[41] Z. Khachaturian. Alzheimer's & Dementia: The Journal of the Alzheimer's Association , 2008, Alzheimer's & Dementia.
[42] F. Schmidt. Meta-Analysis , 2008 .
[43] H. Neumann,et al. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 , 2005, The Journal of experimental medicine.
[44] H. D. de Melker,et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe , 2004, Sexually Transmitted Infections.
[45] L. Peltonen,et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. , 2002, American journal of human genetics.
[46] Leena Peltonen,et al. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts , 2000, Nature Genetics.
[47] G. Wilcock,et al. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.
[48] M. Hirsch,et al. Acute viral encephalitis. , 1985, The Medical clinics of North America.
[49] A. Frydén,et al. ACYCLOVIR VERSUS VIDARABINE IN HERPES SIMPLEX ENCEPHALITIS Randomised Multicentre Study in Consecutive Swedish Patients , 1984, The Lancet.